Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Supplemental content
IMPORTANCE Alternate-day fasting has become increasingly popular, yet, to date, no
long-term randomized clinical trials have evaluated its efficacy.
DESIGN, SETTING, AND PARTICIPANTS A single-center randomized clinical trial of obese adults
(18 to 64 years of age; mean body mass index, 34) was conducted between October 1, 2011,
and January 15, 2015, at an academic institution in Chicago, Illinois.
MAIN OUTCOMES AND MEASURES The primary outcome was change in body weight.
Secondary outcomes were adherence to the dietary intervention and risk indicators for
cardiovascular disease.
RESULTS Among the 100 participants (86 women and 14 men; mean [SD] age, 44 [11] years),
the dropout rate was highest in the alternate-day fasting group (13 of 34 [38%]), vs the daily
calorie restriction group (10 of 35 [29%]) and control group (8 of 31 [26%]). Mean weight loss
was similar for participants in the alternate-day fasting group and those in the daily calorie
restriction group at month 6 (–6.8% [95% CI, –9.1% to –4.5%] vs –6.8% [95% CI, –9.1% to
–4.6%]) and month 12 (–6.0% [95% CI, –8.5% to –3.6%] vs –5.3% [95% CI, –7.6% to –3.0%])
relative to those in the control group. Participants in the alternate-day fasting group ate more
than prescribed on fast days, and less than prescribed on feast days, while those in the daily
Author Affiliations: Department of
calorie restriction group generally met their prescribed energy goals. There were no
Kinesiology and Nutrition, University
significant differences between the intervention groups in blood pressure, heart rate, of Illinois at Chicago (Trepanowski,
triglycerides, fasting glucose, fasting insulin, insulin resistance, C-reactive protein, or Kroeger, Barnosky, Klempel, Bhutani,
homocysteine concentrations at month 6 or 12. Mean high-density lipoprotein cholesterol Hoddy, Gabel, Varady); Nutrition
Obesity Research Center, University
levels at month 6 significantly increased among the participants in the alternate-day fasting of Alabama at Birmingham (Kroeger);
group (6.2 mg/dL [95% CI, 0.1-12.4 mg/dL]), but not at month 12 (1.0 mg/dL [95% CI, –5.9 to Department of Epidemiology and
7.8 mg/dL]), relative to those in the daily calorie restriction group. Mean low-density Biostatistics, University of Illinois at
Chicago (Freels); Quantitative
lipoprotein cholesterol levels were significantly elevated by month 12 among the participants
Sciences Unit, Stanford University,
in the alternate-day fasting group (11.5 mg/dL [95% CI, 1.9-21.1 mg/dL]) compared with those Stanford, California (Rigdon);
in the daily calorie restriction group. Nutrition Obesity Research Center,
Pennington Biomedical Research
Center, Baton Rouge, Louisiana
CONCLUSIONS AND RELEVANCE Alternate-day fasting did not produce superior adherence,
(Rood, Ravussin).
weight loss, weight maintenance, or cardioprotection vs daily calorie restriction.
Corresponding Author: Krista A.
Varady, PhD, Department of
TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT00960505 Kinesiology and Nutrition, University
of Illinois at Chicago, 1919 W Taylor St,
JAMA Intern Med. 2017;177(7):930-938. doi:10.1001/jamainternmed.2017.0936 Room 532, Chicago, IL 60612 (varady
Published online May 1, 2017. @uic.edu).
T
he first-line therapy prescribed to obese patients for
weight loss is daily calorie restriction.1 However, many Key Points
patients find it difficult to adhere to a conventional
Question Is alternate-day fasting more effective for weight loss
weight-loss diet because food intake must be limited every and weight maintenance compared with daily calorie restriction?
day. 2 As such, adherence to daily calorie restriction de-
Findings This randomized clinical trial included 100 metabolically
creases after 1 month and continues to decline thereafter.3-5
healthy obese adults. Weight loss after 1 year in the alternate-day
In light of this limitation, another approach that requires
fasting group (6.0%) was not significantly different from that of
individuals to restrict calories only every other day was the daily calorie restriction group (5.3%), relative to the
developed.6 This strategy is called alternate-day fasting and no-intervention control group.
involves a fast day where individuals consume 25% of their
Meaning Alternate-day fasting does not produce superior weight
usual intake (approximately 500 kcal), alternated with a “feast
loss or weight maintenance compared with daily calorie
day” where individuals are permitted to consume food ad li- restriction.
bitum. Findings from short-term studies indicate that partici-
pants lose 3% to 7% of body weight after 2 to 3 months of al-
ternate-day fasting and experience improvements in lipid for the Protection of Research Subjects at the University of
profiles, blood pressure, and insulin sensitivity.7-13 Illinois at Chicago, and written informed consent was ob-
Alternate-day fasting regimens have increased in popu- tained from all participants. The full protocol is available in
larity during the past decade, and several best-selling diet Supplement 1.
books14,15 have promoted this approach. More than 1 million
copies of these books have been sold in the United States and Randomization and Intervention Groups
United Kingdom to date. Despite the growing popularity of al- Participants were randomized in a 1:1:1 ratio to an alternate-
ternate-day fasting, to our knowledge, no long-term random- day fasting group, daily calorie restriction group, or no-
ized clinical trials have evaluated its efficacy or compared this intervention control group. Randomization was performed by
regimen with a conventional weight-loss diet. a stratified random sampling procedure by sex, age (18-42 years
We conducted a 1-year, randomized clinical trial to com- and 43-65 years), and body mass index (25.0-32.5 and 32.6-
pare the effects of alternate-day fasting vs daily calorie restric- 39.9). Block size ranged from 1 to 11 participants. The active
tion on body weight and risk indicators for cardiovascular trial duration was 1 year and consisted of a baseline phase (1
disease. We hypothesized that the participants in the alternate- month), a weight-loss phase (6 months), and a weight-
day fasting group would be more adherent to their diet, achieve maintenance phase (6 months) (eFigure 1 in Supplement 2).
greater weight loss, and experience more pronounced improve- We chose this design because weight loss typically peaks at 6
ments in risk indicators for cardiovascular disease during the months during a lifestyle intervention.16 During the baseline
6-month weight-loss phase compared with those in the daily phase, all participants ate their usual diet and maintained a
calorie restriction group. We also hypothesized that the alter- stable weight. Baseline total energy expenditure was mea-
nate-day fasting group would better maintain their weight loss sured using doubly labeled water.17 All participants were in-
and sustain their improvements in risk indicators for cardio- structed not to change their physical activity habits through-
vascular disease during the 6-month weight-maintenance phase out the trial (eg, not to join a gym) to avoid potential
compared with the daily calorie restriction group. confounding.
Weight-Loss Phase
Participants in the alternate-day fasting group and those in the
Methods daily calorie restriction group were provided with all meals dur-
Participants ing the first 3 months of the trial and received dietary coun-
We conducted the trial between October 1, 2011, and January seling thereafter (eFigure 1 in Supplement 2). During the
15, 2015, at the University of Illinois at Chicago. Participants 6-month weight-loss phase, the intervention groups were in-
were recruited from the Chicago area by means of flyers placed structed to reduce their energy intake by a mean of 25% per
around the university and were screened via a questionnaire, day. To achieve this reduction, the alternate-day fasting group
an assessment of body mass index, and a pregnancy test. In- was instructed to consume 25% of baseline energy intake as a
dividuals included were men and women between 18 and 65 lunch (between 12 PM and 2 PM) on fast days and 125% of base-
years of age, with a body mass index between 25.0 and 39.9 line energy intake split between 3 meals on alternating feast
(calculated as weight in kilograms divided by height in me- days. The daily calorie restriction group was instructed to con-
ters squared) who had previously been sedentary (<60 min- sume 75% of baseline energy intake split between 3 meals ev-
utes per week of light activity for the 3 months prior to the ery day. The provided meals were in accordance with the
study). Exclusion criteria were a history of cardiovascular dis- American Heart Association guidelines18 for macronutrient in-
ease or type 1 or 2 diabetes, use of medications that could affect take, with 30% of energy as fat, 55% as carbohydrate, and 15%
study outcomes, unstable weight for 3 months prior to the be- as protein. From months 4 to 6, when food was no longer pro-
ginning of the study (>4-kg weight loss or gain), perimeno- vided, intervention participants met individually with a di-
pause or otherwise irregular menstrual cycle, pregnancy, and etician or nutritionist weekly to learn how to continue with
currently smoking. The protocol was approved by the Office their diets on their own.
jamainternalmedicine.com (Reprinted) JAMA Internal Medicine July 2017 Volume 177, Number 7 931
932 JAMA Internal Medicine July 2017 Volume 177, Number 7 (Reprinted) jamainternalmedicine.com
122 Excluded
114 Did not meet ≥1 inclusion criteria
8 Declined to participate
100 Randomized
rie restriction group were adherent to their energy goals at ence between the intervention groups. Weight regain from
months 3, 6, 9, and 12 relative to those in the alternate-day fast- months 6 to 12 (–0.8%; 95% CI, –3.2% to 1.7%) was not signifi-
ing group. cantly different between the alternate-day fasting group and
the daily calorie restriction group. Moreover, weight regain
Percentage Energy Restriction Determined from months 6 to 12 was not significantly different between
via Doubly Labeled Water the alternate-day fasting group and controls (0.8%; 95% CI,
From baseline to month 6, the alternate-day fasting group –1.8% to 3.3%), or the daily calorie restriction group and con-
achieved a mean (SD) percentage energy restriction of 21% trols (1.5%; 95% CI, –0.8% to 3.9%). Changes in body compo-
(16%), and the daily calorie restriction group achieved a mean sition are reported in Table 2. There were no statistically sig-
(SD) percentage energy restriction of 24% (16%), with no sig- nificant differences between the alternate-day fasting group
nificant difference between the intervention groups or com- and the daily calorie restriction group for fat mass, lean mass,
pared with the control group (eFigure 2 in Supplement 2). or visceral fat mass at month 6 or month 12.
Physical Activity and Dietary Intake Blood Pressure and Heart Rate
Data on dietary intake are displayed in eTable 1 in Supplement Blood pressure was not significantly different between the in-
2. Percentage of energy intake from fat, carbohydrates, and pro- tervention groups, or relative to controls, at month 6 or month
tein did not differ significantly over time in any of the groups. 12 (Table 2). There were also no statistically significant differ-
Physical activity, measured as steps per day, did not change ences in heart rate between the alternate-day fasting group and
during the course of the trial in any group (eTable 2 in the daily calorie restriction group at month 6 or month 12
Supplement 2). This level of activity is approximately 1000 to (Table 2).
2000 steps per day higher than that of the average over-
weight or obese adult.25 Plasma Lipids
Changes in plasma lipids during the course of the trial are
Weight Loss and Weight Maintenance shown in Table 2. Total cholesterol levels were not signifi-
Changes in body weight are displayed in Figure 3 and Table 2. cantly different between the intervention groups, or relative
Weight loss was not significantly different between the alter- to controls, at month 6 or month 12. At month 6, high-density
nate-day fasting group and the daily calorie restriction group lipoprotein cholesterol levels were significantly elevated in the
at month 6. At the end of the study, total weight loss was –6.0% alternate-day fasting group by 6.2 mg/dL (95% CI, 0.1-12.4 mg/
(95% CI, –8.5% to –3.6%) for the alternate-day fasting group dL) (to convert to millimoles per liter, multiply by 0.0259) vs
and –5.3% (95% CI, –7.6% to –3.0%) for the daily calorie re- the daily calorie restriction group, but this effect was no lon-
striction group, relative to controls, with no significant differ- ger observed by month 12. Low-density lipoprotein choles-
jamainternalmedicine.com (Reprinted) JAMA Internal Medicine July 2017 Volume 177, Number 7 933
terol concentrations did not differ significantly between the els did not differ significantly between the intervention groups
intervention groups at month 6. At month 12, low-density li- at month 6 or month 12.
poprotein cholesterol levels significantly increased in the al-
ternate-day fasting group (11.5 mg/dL [95% CI, 1.9-21.1 mg/ Glucoregulatory and Inflammatory Factors
dL]) (to convert to millimoles per liter, multiply by 0.0259) Changes in glucoregulatory and inflammatory factors are
relative to the daily calorie restriction group. Triglyceride lev- displayed in Table 2. Fasting plasma glucose did not differ
934 JAMA Internal Medicine July 2017 Volume 177, Number 7 (Reprinted) jamainternalmedicine.com
Figure 2. Prescribed vs Actual Energy Intake in the Alternate-Day Fasting and Daily Calorie Restriction Groups
A Fast day for alternate-day fasting group B Feast day for alternate-day fasting group C Every day for daily calorie restriction group
4000 4000 4000
3000 3000 a
3000
a
Energy, kcal
Energy, kcal
Energy, kcal
2500 2500 2500 a
a a
2000 2000 2000
a
1500 a
1500 1500
0 0 0
Baseline 3 6 9 12 Baseline 3 6 9 12 Baseline 3 6 9 12
Study Month Study Month Study Month
Actual energy intake assessed via a 7-day food record at baseline and months 3, calorie restriction group was significantly lower (P < .05) than the prescribed
6, 9, and 12. A, Actual energy intake assessed via a 7-day food record at baseline energy goal. Data are expressed as mean (SD) values; only observed values
and months 3, 6, 9, and 12 in the alternate-day fasting group on the fast day was were included. The weight-loss period was from baseline to month 6; the
significantly (P < .05) higher than the prescribed energy goal at months 3 and 6. weight-maintenance period was from month 6 to month 12. Error bars indicate
B, Actual energy intake assessed via a 7-day food record at baseline and months 95% CI.
3, 6, 9, and 12 in the alternate-day fasting group on the feast day was a
Significant difference between prescribed energy intake and actual energy
significantly lower (P < .001) than the prescribed energy goal at months 3, 6, 9, intake at a particular month in the study.
and 12. C, Participants in the daily calorie restriction group met their prescribed
energy goal at months 3, 6, and 12. At month 9, actual energy intake in the daily
2
1
0
–1
Mean Weight Change, %
–2
–3
–4
–5
Data were included for 100
–6
participants; mean (SD) values were
–7 estimated using an intention-to-treat
Control group
–8 ADF group analysis with a linear mixed model.
–9 DCR group Error bars indicate 95% CIs for
–10 weight change from baseline by diet
1 2 3 4 5 6 7 8 9 10 11 12 group at each time point (1-12
Duration of Intervention, mo months). ADF indicates alternate-day
fasting; DCR, daily calorie restriction.
jamainternalmedicine.com (Reprinted) JAMA Internal Medicine July 2017 Volume 177, Number 7 935
Table 2. Pairwise Effects Estimates of Diet on Mean Changes From Baseline in Body Weight and Risk Indicators for Cardiovascular Diseasea
Change in ADF − Change in DCR Change in ADF − Change in Control Change in DCR − Change in Control
(95% CI) (95% CI) (95% CI)
Outcome Variable At 6 mo At 12 mo At 6 mo At 12 mo At 6 mo At 12 mo
Body weight, % change 0.0 −0.7 −6.8 −6.0 −6.8 −5.3
(−2.2 to 2.2) (−3.1 to 1.6) (−9.1 to −4.5) (−8.5 to −3.6) (−9.1 to −4.6) (−7.6 to −3.0)
Fat mass, kg 0.9 0.0 −4.2 −2.0 −5.1 −2.0
(−1.3 to 3.1) (−2.4 to 2.4) (−6.6 to −1.8) (−4.4 to 0.5) (−7.5 to −2.7) (−4.4 to 0.4)
Lean mass, kg 0.6 0.5 −1.5 −0.9 −2.1 −1.4
(−1.0 to 2.2) (−1.2 to 2.2) (−3.2 to 0.2) (−2.7 to 0.9) (−3.8 to 0.4) (−3.1 to 0.3)
Visceral fat mass, kg 0.2 0.1 −0.4 −0.4 −0.6 −0.5
(−0.1 to 0.5) (−0.2 to 0.5) (−0.7 to −0.1) (−0.7 to −0.1) (−0.9 to −0.2) (−0.8 to −0.2)
Blood pressure, mm Hg
Systolic 0.8 −1.1 −3.1 −2.3 −3.9 −1.24
(−7.1 to 8.7) (−9.5 to 7.4) (−11.3 to 5.2) (−11.0 to 6.4) (−12.1 to 4.4) (−9.7 to 7.2)
Diastolic −0.3 −3.0 −1.5 −0.1 −1.2 2.9
(−5.9 to 5.4) (−9.0 to 3.0) (−7.4 to 4.4) (−6.3 to 6.1) (−7.1 to 4.6) (−3.1 to 8.9)
Heart rate, beats/min −4.9 −2.0 −5.8 −1.2 −0.9 0.8
(−10.1 to 0.4) (−7.7 to 3.8) (−11.3 to −0.3) (−7.1 to 4.7) (−6.4 to 4.5) (−4.8 to 6.4)
Cholesterol, mg/dL
Total 3.4 9.7 −4.3 4.2 −7.6 −5.6
(−7.2 to 13.9) (−2.2 to 21.7) (−15.4 to 6.9) (−8.2 to 16.5) (−18.8 to 3.6) (−17.6 to 6.4)
HDL 6.2 1.0 8.4 2.9 2.2 1.9
(0.1 to 12.4) (−5.9 to 7.8) (1.9 to 14.7) (−4.2 to 10.0) (−4.3 to 8.7) (−5.1 to 8.9)
LDL 2.5 11.5 −2.6 1.2 −5.0 −10.3
(−6.0 to 10.9) (1.9 to 21.1) (−11.5 to 6.4) (−8.7 to 11.2) (−14.0 to 3.9) (−19.9 to −0.6)
Triglycerides, mg/dL −10.5 −9.9 −19.1 −24.4 −8.6 −14.5
(−26.7 to 5.8) (−28.3 to 8.6) (−36.3 to −1.8) (−43.5 to −5.3) (−25.9 to 8.7) (−33.1 to 4.0)
Glucose, mg/dL −1.4 5.7 −6.3 −3.9 −4.9 −9.6
(−8.0 to 5.2) (−1.6 to 13.0) (−13.3 to 0.7) (−11.5 to 3.6) (−12.0 to 2.1) (−17.1 to −2.2)
Insulin, μIU/mL −0.4 −1.3 −7.5 −5.9 −7.0 −4.6
(−5.5 to 4.7) (−6.9 to 4.3) (−12.9 to −2.0) (−11.7 to −0.1) (−12.5 to −1.6) (−10.4 to 1.2)
HOMA-IRa 0.07 0.02 −2.49 −1.86 −2.56 −1.88
(−1.56 to 1.70) (−1.78 to 1.81) (−4.22 to −0.76) (−3.73 to 0.01) (−4.30 to −0.82) (−3.72 to −0.03)
HS CRP, mg/dL −0.04 0.00 −0.07 −0.07 −0.04 −0.07
(−0.19 to 0.11) (−0.16 to 0.17) (−0.23 to 0.08) (−0.24 to 0.11) (−0.19 to 0.12) (−0.24 to 0.10)
Homocysteine, mg/L 0.03 0.03 0.10 0.02 0.06 −0.01
(−0.10 to 0.17) (−0.12 to 0.18) (−0.04 to 0.24) (−0.13 to 0.18) (−0.08 to 0.20) (−0.16 to 0.14)
Abbreviations: ADF, alternate-day fasting; DCR, daily calorie restriction; per liter, multiply by 0.0259; to convert triglycerides to millimoles per liter,
HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment of multiply by 0.0113; to convert glucose to millimoles per liter, multiply by
insulin resistance [calculated as insulin × glucose/405, where the unit of 0.0555; to convert insulin to picomoles per liter, multiply by 6.945; and to
measure for insulin is in micro-international units per milliliter and the unit of convert homocysteine to micromoles per liter, multiply by 7.397.
measure for glucose is milligrams per deciliter]; HS CRP, high-sensitivity a
Data were included for 100 participants; mean (SD) values were estimated
C-reactive protein; LDL, low-density lipoprotein. using an intention-to-treat analysis with a linear mixed model.
SI conversion factors: To convert total, HDL, and LDL cholesterol to millimoles
case. Rather, it appears as though many participants in the al- ternate-day fasting reported weight loss of 3% to 7% after 2 to
ternate-day fasting group converted their diet into de facto 3 months of diet.7-13 Adherence was measured in several pre-
calorie restriction as the trial progressed. Moreover, the drop- vious trials and was shown to be high (eg, participants met their
out rate in the alternate-day fasting group (38%) was higher calorie goals on approximately 80%-90% of fast days).7,8,10,11
than that in the daily calorie restriction group (29%) and the Most of these past studies provided food on the fast day,7,8,10,11
control group (26%). It was also shown that more partici- so the provision of food is not a confounder when comparing
pants in the alternate-day fasting group withdrew owing to dis- past findings with present findings. Food was provided to the
satisfaction with diet compared with those in the daily calo- intervention participants during the first 3 months of the
rie restriction group (Figure 1). Taken together, these findings weight-loss phase to promote adherence26 and show partici-
suggest that alternate-day fasting may be less sustainable in pants the types and quantities of foods that they should be eat-
the long term, compared with daily calorie restriction, for most ing. Data from the food records indicated that participants fre-
obese individuals. Nevertheless, it is still possible that a cer- quently ate extra “nonstudy” foods that were purchased from
tain smaller segment of obese individuals may prefer this pat- stores or restaurants. This finding suggests that limiting ca-
tern of energy restriction instead of daily restriction. It will be loric intake to approximately 500 kcal every other day may
of interest to examine what behavioral traits (eg, ability to go have been difficult for many participants early in the inter-
for long periods without eating) make alternate-day fasting vention. Future work in this area should examine whether this
more tolerable for some individuals than others. lack of adherence to alternate-day fasting is due to cognitive,
To our knowledge, the present study is the longest and larg- environmental, and/or physiological factors. For instance, mea-
est trial of alternate-day fasting to date. Previous trials of al- suring changes in subjective appetite (hunger and fullness) in
936 JAMA Internal Medicine July 2017 Volume 177, Number 7 (Reprinted) jamainternalmedicine.com
conjunction with modulations in appetite hormones (ghre- ings. We also failed to include the control group in our initial
lin, peptide YY, and glucagon-like peptide-1) could offer some power calculation. Third, since the dropout rate was higher
insight into why daily calorie restriction may allow for easier than anticipated, our power to detect the hypothesized differ-
adherence compared with alternate-day fasting. ence of 5% weight loss between the intervention groups at
Contrary to our original hypotheses, the participants in the month 6 decreased from 80% to 60%. The higher dropout
alternate-day fasting group did not experience more pro- rate in the alternate-day fasting group may have also intro-
nounced improvements in risk indicators for cardiovascular duced a possible selection bias between groups.27 Finally, we
disease compared with the participants in the daily calorie re- enrolled predominantly metabolically healthy obese indi-
striction group. However, the trial included primarily meta- viduals, which may have hindered the abilities of the inter-
bolically healthy obese adults. Since many of the participants ventions to produce greater improvements in our measured
had normal cholesterol levels and normal blood pressure at cardiovascular disease risk indicators.28,29 The generalizabil-
baseline, it is not surprising that most risk indicators for car- ity of our findings is also limited by the enrollment.
diovascular disease did not change in response to diet.
Limitations
Our study has several limitations. First, the duration of the
Conclusions
maintenance phase was short (6 months). Second, the control The alternate-day fasting diet was not superior to the daily calo-
group was imperfect, in that they received no food, no coun- rie restriction diet with regard to adherence, weight loss, weight
seling, and less attention from study personnel, relative to the maintenance, or improvement in risk indicators for cardio-
intervention groups, which may have confounded our find- vascular disease.
jamainternalmedicine.com (Reprinted) JAMA Internal Medicine July 2017 Volume 177, Number 7 937
18. Eckel RH, Jakicic JM, Ard JD, et al; American and changes in body composition. Am J Clin Nutr. 25. Tudor-Locke C, Brashear MM, Johnson WD,
College of Cardiology/American Heart Association 2007;85(1):73-79. Katzmarzyk PT. Accelerometer profiles of physical
Task Force on Practice Guidelines. 2013 AHA/ACC 22. Johannsen DL, Calabro MA, Stewart J, Franke activity and inactivity in normal weight, overweight,
guideline on lifestyle management to reduce W, Rood JC, Welk GJ. Accuracy of armband and obese US men and women. Int J Behav Nutr
cardiovascular risk: a report of the American monitors for measuring daily energy expenditure in Phys Act. 2010;7:60.
College of Cardiology/American Heart Association healthy adults. Med Sci Sports Exerc. 2010;42(11): 26. Hall DM, Most MM. Dietary adherence in
Task Force on Practice Guidelines. Circulation. 2014; 2134-2140. well-controlled feeding studies. J Am Diet Assoc.
129(25)(suppl 2):S76-S99. 2005;105(8):1285-1288.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor
19. Laliberte M, McCabe RE, Taylor V. The Cognitive BA, Treacher DF, Turner RC. Homeostasis model 27. Hernán MA, Hernández-Díaz S, Robins JM.
Behavioral Workbook for Weight Management: assessment: insulin resistance and beta-cell A structural approach to selection bias. Epidemiology.
A Step-by-Step Program. Oakland, CA: New Harbinger function from fasting plasma glucose and insulin 2004;15(5):615-625.
Publications; 2009. concentrations in man. Diabetologia. 1985;28(7): 28. Janiszewski PM, Ross R. Effects of weight loss
20. Demerath EW, Ritter KJ, Couch WA, et al. 412-419. among metabolically healthy obese men and
Validity of a new automated software program for 24. Redman LM, Rood J, Anton SD, Champagne C, women. Diabetes Care. 2010;33(9):1957-1959.
visceral adipose tissue estimation. Int J Obes (Lond). Smith SR, Ravussin E; Pennington Comprehensive
2007;31(2):285-291. 29. Kantartzis K, Machann J, Schick F, et al. Effects
Assessment of Long-Term Effects of Reducing of a lifestyle intervention in metabolically benign
21. de Jonge L, DeLany JP, Nguyen T, et al. Intake of Energy (CALERIE) Research Team. Calorie and malign obesity. Diabetologia. 2011;54(4):
Validation study of energy expenditure and intake restriction and bone health in young, overweight 864-868.
during calorie restriction using doubly labeled water individuals. Arch Intern Med. 2008;168(17):
1859-1866.
938 JAMA Internal Medicine July 2017 Volume 177, Number 7 (Reprinted) jamainternalmedicine.com